Literature DB >> 23587424

Kappa-opioid receptor-selective dicarboxylic ester-derived salvinorin A ligands.

Prabhakar R Polepally1, Kate White, Eyal Vardy, Bryan L Roth, Daneel Ferreira, Jordan K Zjawiony.   

Abstract

Salvinorin A, the active ingredient of the hallucinogenic plant Salvia divinorum is the most potent known naturally occurring hallucinogen and is a selective κ-opioid receptor agonist. To better understand the ligand-receptor interactions, a series of dicarboxylic ester-type of salvinorin A derivatives were synthesized and evaluated for their binding affinity at κ-, δ- and μ-opioid receptors. Most of the analogues show high affinity to the κ-opioid receptor. Methyl malonyl derivative 4 shows the highest binding affinity (Ki=2nM), analogues 5, 7, and 14 exhibit significant affinity for the κ-receptor (Ki=21, 36 and 39nM).
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23587424      PMCID: PMC3651692          DOI: 10.1016/j.bmcl.2013.03.111

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  15 in total

1.  Synthesis and in vitro pharmacological studies of new C(4)-modified salvinorin A analogues.

Authors:  David Y W Lee; Minsheng He; Lee-Yuan Liu-Chen; Yulin Wang; Jian-Guo Li; Wei Xu; Zhongze Ma; William A Carlezon; Bruce Cohen
Journal:  Bioorg Med Chem Lett       Date:  2006-08-30       Impact factor: 2.823

2.  Bioisosteric modification of salvinorin A, a potent and selective kappa-opioid receptor agonist.

Authors:  D Jeremy Stewart; Hesham Fahmy; Bryan L Roth; Feng Yan; Jordan K Zjawiony
Journal:  Arzneimittelforschung       Date:  2006

3.  Synthesis of salvinorin A analogues as opioid receptor probes.

Authors:  Kevin Tidgewell; Wayne W Harding; Anthony Lozama; Howard Cobb; Kushal Shah; Pavitra Kannan; Christina M Dersch; Damon Parrish; Jeffrey R Deschamps; Richard B Rothman; Thomas E Prisinzano
Journal:  J Nat Prod       Date:  2006-06       Impact factor: 4.050

4.  Structure-based design, synthesis, and biochemical and pharmacological characterization of novel salvinorin A analogues as active state probes of the kappa-opioid receptor.

Authors:  Feng Yan; Ruslan V Bikbulatov; Viorel Mocanu; Nedyalka Dicheva; Carol E Parker; William C Wetsel; Philip D Mosier; Richard B Westkaemper; John A Allen; Jordan K Zjawiony; Bryan L Roth
Journal:  Biochemistry       Date:  2009-07-28       Impact factor: 3.162

5.  Synthesis and in vitro evaluation of salvinorin A analogues: effect of configuration at C(2) and substitution at C(18).

Authors:  Cécile Béguin; Michele R Richards; Jian-Guo Li; Yulin Wang; Wei Xu; Lee-Yuan Liu-Chen; William A Carlezon; Bruce M Cohen
Journal:  Bioorg Med Chem Lett       Date:  2006-06-13       Impact factor: 2.823

6.  Convenient synthesis and in vitro pharmacological activity of 2-thioanalogs of salvinorins A and B.

Authors:  Ruslan V Bikbulatov; Feng Yan; Bryan L Roth; Jordan K Zjawiony
Journal:  Bioorg Med Chem Lett       Date:  2007-02-02       Impact factor: 2.823

7.  Synthesis and biological evaluation of C-2 halogenated analogs of salvinorin A.

Authors:  David Y W Lee; Lu Yang; Wei Xu; Gang Deng; Lin Guo; Lee-Yuan Liu-Chen
Journal:  Bioorg Med Chem Lett       Date:  2010-08-05       Impact factor: 2.823

8.  Neoclerodane diterpenes as a novel scaffold for mu opioid receptor ligands.

Authors:  Wayne W Harding; Kevin Tidgewell; Nathan Byrd; Howard Cobb; Christina M Dersch; Eduardo R Butelman; Richard B Rothman; Thomas E Prisinzano
Journal:  J Med Chem       Date:  2005-07-28       Impact factor: 7.446

9.  Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist.

Authors:  Bryan L Roth; Karen Baner; Richard Westkaemper; Daniel Siebert; Kenner C Rice; SeAnna Steinberg; Paul Ernsberger; Richard B Rothman
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-21       Impact factor: 11.205

10.  Structure of the human κ-opioid receptor in complex with JDTic.

Authors:  Huixian Wu; Daniel Wacker; Mauro Mileni; Vsevolod Katritch; Gye Won Han; Eyal Vardy; Wei Liu; Aaron A Thompson; Xi-Ping Huang; F Ivy Carroll; S Wayne Mascarella; Richard B Westkaemper; Philip D Mosier; Bryan L Roth; Vadim Cherezov; Raymond C Stevens
Journal:  Nature       Date:  2012-03-21       Impact factor: 49.962

View more
  7 in total

Review 1.  Clerodane diterpenes: sources, structures, and biological activities.

Authors:  Rongtao Li; Susan L Morris-Natschke; Kuo-Hsiung Lee
Journal:  Nat Prod Rep       Date:  2016-07-18       Impact factor: 13.423

2.  Salvinorin A analogues PR-37 and PR-38 attenuate compound 48/80-induced itch responses in mice.

Authors:  M Salaga; P R Polepally; M Zielinska; M Marynowski; A Fabisiak; N Murawska; K Sobczak; M Sacharczuk; J C Do Rego; B L Roth; J K Zjawiony; J Fichna
Journal:  Br J Pharmacol       Date:  2015-07-14       Impact factor: 8.739

Review 3.  A review of salvinorin analogs and their kappa-opioid receptor activity.

Authors:  Jeremy J Roach; Ryan A Shenvi
Journal:  Bioorg Med Chem Lett       Date:  2018-03-12       Impact factor: 2.823

4.  Addressing Structural Flexibility at the A-Ring on Salvinorin A: Discovery of a Potent Kappa-Opioid Agonist with Enhanced Metabolic Stability.

Authors:  Alexander M Sherwood; Rachel Saylor Crowley; Kelly F Paton; Andrew Biggerstaff; Benjamin Neuenswander; Victor W Day; Bronwyn M Kivell; Thomas E Prisinzano
Journal:  J Med Chem       Date:  2017-04-19       Impact factor: 7.446

5.  Michael acceptor approach to the design of new salvinorin A-based high affinity ligands for the kappa-opioid receptor.

Authors:  Prabhakar R Polepally; Krzysztof Huben; Eyal Vardy; Vincent Setola; Philip D Mosier; Bryan L Roth; Jordan K Zjawiony
Journal:  Eur J Med Chem       Date:  2014-08-23       Impact factor: 6.514

6.  Stilbenes as κ-selective, non-nitrogenous opioid receptor antagonists.

Authors:  Alyssa M Hartung; John A Beutler; Hernán A Navarro; David F Wiemer; Jeffrey D Neighbors
Journal:  J Nat Prod       Date:  2014-01-23       Impact factor: 4.050

Review 7.  Natural Products for the Treatment of Pain: Chemistry and Pharmacology of Salvinorin A, Mitragynine, and Collybolide.

Authors:  Soumen Chakraborty; Susruta Majumdar
Journal:  Biochemistry       Date:  2020-09-22       Impact factor: 3.162

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.